Ceragenix and FirstPoint Biotech sign licensing agreement
Pursuant to the terms of the agreement, FirstPoint Biotech (FPBT) will have the responsibility to undertake the clinical development and commercialization of these compounds within these fields of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.